Beijing, China - In a significant breakthrough in the field of in vitro diagnostic reagents, Beijing Beier Bioengineering Co., Ltd. has announced the development of a revolutionary Igm Self Test that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Osteocalcin Assay to its pr

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China, has recently released its latest innovation, a Glucose Elisa Kit, designed for the accurate and efficient measurement of glucos

Beijing Beier Bioengineering Co., Ltd. has recently developed a revolutionary new diagnostic tool to aid in the detection of various medical conditions. The company, established in Beijing in Septembe

Beijing Beier Bioengineering Co., Ltd. Introduces New Breakthrough in In Vitro Diagnostics Beijing, China - Beijing Beier Bioengineering Co., Ltd. is proud to announce the development of a new Elisa

Beijing Beier Bioengineering Co., Ltd. is making waves in the field of in vitro diagnostic reagents with the introduction of their latest product, Clinical Chemistry And Immunoassay. Established in Be

Beijing Beier Bioengineering Co., Ltd. has recently developed a new in vitro diagnostic reagent called Autotest Antigen, which is set to significantly improve the efficiency and accuracy of antigen te

Beijing Beier Bioengineering Co., Ltd (Beier Bioengineering) has recently announced the successful development of a new product, Anti Treponema Pallidum, a groundbreaking in vitro diagnostic reagent.

Beijing Beier Bioengineering Co., Ltd. is a high-tech enterprise specializing in the development and production of in vitro diagnostic reagents. Established in Beijing in September 1995, the company h

Beijing Beier Bioengineering Co., Ltd. has recently developed a new rapid testing kit for the detection of Igm and Igg antibodies, which could potentially revolutionize the way the COVID-19 virus is d